Head and Neck Cancers Panel - Disclosures
Panel Member
|
Douglas Adkins MD |
Grant/Research Support
|
| Adlai-Nortye | Alentis | Astrazeneca | AVEO Pharmaceuticals, Inc. | Boehringer Ingelheim GmbH | Coherus | CUE | Daiichi Sankyo | Eisai Inc. | Eli Lilly and Company | EMD Serono | Genmab | Gilead Sciences, Inc. | GSK | Inhibrx | Johnson and Johnson | Kura Oncology, Inc. | Merck & Co., Inc. | Merus | Natco | Pfizer | Regeneron Pharmactcls | Seagen | Takeda |
Date Completed
|
08/04/2024 |
Panel Member
|
Andrew Birkeland MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Brizel MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Paul Busse MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jimmy Caudell MD, PhD |
Grant/Research Support
|
| Varian Medical Systems, Inc. |
Date Completed
|
06/07/2024 |
Panel Member
|
Anthony Cmelak MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
A. Dimitrios Colevas MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Susan Darlow PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Gregory Durm MD, MS |
Grant/Research Support
|
| Bristol Myers Squibb | Merck & Co., Inc. |
Date Completed
|
05/13/2025 |
Panel Member
|
Carole Fakhry MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tanya Fischer MEd, MLIS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Thomas Galloway MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jessica Geiger MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Maura Gillison MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Christine Glastonbury MBBS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Robert Haddad MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kyle Herrmann BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Wesley Hicks, Jr. MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ying Hitchcock MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Anne Holbrook PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Antonio Jimeno MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Aditya Juloori MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Michael Kase DMD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Alexander Ladenheim MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Debra Leizman MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ellie Maghami MD, FACS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Loren Mell MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Bharat Mittal MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sarah Montgomery |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristen Morris BSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Svitlana Ostanina PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Pfister MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Harlan Pinto MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Katharine Price MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
James Rocco MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Cristina Rodriguez MD |
Grant/Research Support
|
| Adagene | Ayala Pharmaceuticals | Bristol Myers Squibb | Coherus | Cue Biopharma | Kura | Merck & Co., Inc. | ONCO-C4 | Pfizer Inc. | Prelude Therapeutics | Rgenta | sanofi-aventis U.S. |
Date Completed
|
03/26/2025 |
Panel Member
|
David Schwartz MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jatin Shah MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Sher MD, MPH |
Grant/Research Support
|
| Varian Medical Systems, Inc. |
Date Completed
|
03/18/2025 |
Panel Member
|
Sharon Spencer MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Maie St. John MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Gregory Weinstein MD |
Intellectual Property Rights
|
| Olympus Corportation |
Date Completed
|
01/16/2025 |
Panel Member
|
Francis Worden MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Justine Yang Bruce MD |
Grant/Research Support
|
| Astellas Pharma US, Inc. | Cellectar Biosciences | Eli Lilly and Company | Incyte Corporation | Kura Oncology, Inc. | Natco |
Date Completed
|
07/29/2024 |
Panel Member
|
Sue Yom MD, PhD |
Grant/Research Support
|
| Bristol Myers Squibb | EMD Serono | Johnson & Johnson | Merck & Co., Inc. |
Date Completed
|
05/13/2025 |
Panel Member
|
Weining Zhen MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |